Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants

3 Sept 2021

Abstract excerpt

SARS-CoV-2 variants are developing rapidly among COVID-19 patients, likely resulting in higher transmissibility at the population level. 1 , 2 , 3 , 4 , 5 Mutations in the spike proteins (S proteins) of these variants are supposed to be related with receptor binding and virus invasion. Examples of these prevalent variants include the B.1.1.7 lineage that emerged in the United Kingdom (UK), the B.1.351 lineage...

Topics

Join the communities discussing this publication.

SARS-CoV-2 and COVID-19 Research
Viral gastroenteritis research and epidemiology
Viral Infections and Immunology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34480123
DOI: 10.1038/s41422-021-00554-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variantsPMID 34480123Read ↗

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.Semantic proximity Read ↗

A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding DomainSemantic proximity Read ↗

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variantsSemantic proximity Read ↗

Mutations of SARS-CoV-2 and their impact on disease diagnosis and severitySemantic proximity Read ↗

Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach.Semantic proximity Read ↗

Molecular Insights into the Variability in Infection and Immune Evasion Capabilities of SARS-CoV-2 Variants: A Sequence and Structural Investigation of the RBD Domain.Semantic proximity Read ↗

Epimaps of the SARS-CoV-2 Receptor-Binding Domain Mutational Landscape: Insights into Protein Stability, Epitope Prediction, and Antibody Binding.Semantic proximity Read ↗

SARS-CoV-2 variants resist antibody neutralization and broaden host ACE2 usageSemantic proximity Read ↗

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy.Semantic proximity Read ↗

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Semantic proximity Read ↗

Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico ApproachSemantic proximity Read ↗

Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.